UOC
HLF icon

UBS O'Connor’s Herbalife HLF Stock Holding History

UBS O'Connor’s Portfolio HLF Stock Details HLF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-100,000
Closed -$4.77M – 364
2019
Q4 		$4.77M Sell
100,000
-180,000
-64% -$7.8M 0.13% 133
2019
Q3 		$10.6M Buy
280,000
+115,000
+70% +$4.49M 0.29% 71
2019
Q2 		$7.05M Buy
+165,000
New +$7.81M 0.14% 90
2019
Q1 		– Sell
-500,000
Closed -$29.5M – 78
2018
Q4 		$29.5M Sell
500,000
-50,000
-9% -$2.76M 1.06% 24
2018
Q3 		$30M Sell
550,000
-50,000
-8% -$2.76M 0.69% 34
2018
Q2 		$32.2M Sell
600,000
-200,000
-25% -$10.5M 0.65% 29
2018
Q1 		$39M Sell
800,000
-770,000
-49% -$32.7M 0.75% 25
2017
Q4 		$53.2M Sell
1,570,000
-456,484
-23% -$16M 0.94% 22
2017
Q3 		$68.7M Sell
2,026,484
-97,916
-5% -$3.35M 1% 20
2017
Q2 		$75.8M Buy
2,124,400
+276,856
+15% +$9.33M 1.24% 14
2017
Q1 		$53.7M Sell
1,847,544
-575,152
-24% -$16M 0.91% 23
2016
Q4 		$58.3M Sell
2,422,696
-782,232
-24% -$21.4M 1.13% 17
2016
Q3 		$99.3M Buy
3,204,928
+1,078,556
+51% +$34.1M 1.48% 9
2016
Q2 		$62.2M Buy
2,126,372
+63,400
+3% +$1.9M 1.34% 14
2016
Q1 		$63.5M Sell
2,062,972
-1,488,094
-42% -$38.4M 1.17% 19
2015
Q4 		$95.2M Buy
3,551,066
+498,062
+16% +$13.8M 1.6% 10
2015
Q3 		$83.2M Buy
3,053,004
+160,108
+6% +$4.39M 1.69% 6
2015
Q2 		$79.7M Buy
2,892,896
+431,012
+18% +$10.4M 1.38% 11
2015
Q1 		$52.6M Buy
2,461,884
+443,878
+22% +$7.58M 1.13% 13
2014
Q4 		$38M Sell
2,018,006
-464,410
-19% -$9.94M 0.66% 35
2014
Q3 		$54.3M Buy
2,482,416
+148,892
+6% +$3.98M 0.94% 22
2014
Q2 		$75.3M Buy
2,333,524
+613,124
+36% +$18.8M 0.48% 10
2014
Q1 		$49.3M Buy
1,720,400
+1,186,176
+222% +$39.2M 0.93% 17
2013
Q4 		$21M Buy
534,224
+384,224
+256% +$13.3M 0.39% 93
2013
Q3 		$5.23M Sell
150,000
-297,320
-66% -$9.19M 0.11% 209
2013
Q2 		$10.1M Buy
+447,320
New +$9.52M 0.19% 157

Other funds holding HLF

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
ROIC
Route One Investment Company San Francisco, California $2.35B AUM 11.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS O'Connor's HLF Position: Q1 2020 in Review

UBS O'Connor sold out of Herbalife (HLF) in Q1 2020, closing a stake of 100,000 shares — an estimated $4.77M sold.

UBS O'Connor first reported a position in HLF in Q2 2013 and held it in 26 quarters. The position peaked at $99.3M in Q3 2016. 195 funds tracked by Wall St. Rank hold HLF as of Q1 2020.

  • UBS O'Connor reported no remaining Herbalife position as of Q1 2020 after selling out during the quarter.
  • UBS O'Connor sold 100,000 Herbalife shares in Q1 2020, an estimated $4.77M.
  • UBS O'Connor first reported a position in Herbalife in Q2 2013 and held it in 26 quarters.
  • UBS O'Connor's Herbalife position peaked at $99.3M in Q3 2016.
  • 195 funds tracked by Wall St. Rank held Herbalife as of Q1 2020.

Based on UBS O'Connor's 13F filing for Q1 2020, filed 15 May 2020.